Empowered Funds, LLC

Position in INVA — Innoviva, Inc.

CIK 1592828 NEWTOWN SQUARE, PA

Position in INVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,915,681

+$2,423,808 QoQ

Shares Held

168,055

+125.2% QoQ

Ownership

0.228%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Empowered Funds, LLC holds $226,794,169 across 58 Biotechnology names. INVA ranks #16 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	353,386	$33,260,686
2	HALO	Halozyme Therapeutics, Inc.	384,538	$24,852,688
3	VRTX	Vertex Pharmaceuticals Inc / Ma	41,737	$18,637,235
4	EXEL	Exelixis, Inc.	335,606	$14,394,138
5	REGN	Regeneron Pharmaceuticals, Inc.	15,618	$12,067,088
6	ASND	Ascendis Pharma A/S	51,135	$11,696,107
7	RPRX	Royalty Pharma plc	228,996	$10,984,937
8	ARWR	Arrowhead Pharmaceuticals, Inc.	137,220	$8,603,693

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,915,681	168,055	+125.2%	Shares	Other	2026-05-15
2025-12-31	$1,491,873	74,631	-21.6%	Shares	Other	2026-02-18
2025-03-31	$1,726,483	95,228	-5.6%	Shares	Other	2025-05-16
2024-12-31	$1,749,903	100,859	+5.1%	Shares	Other	2025-01-28
2024-09-30	$1,853,064	95,964	-64.3%	Shares	Other	2024-11-06
2024-06-30	$4,413,010	269,086	+7.7%	Shares	Other	2024-07-30
2024-03-31	$3,807,348	249,826	+8.2%	Shares	Other	2024-05-07
2023-12-31	$3,704,213	230,936	+9.9%	Shares	Other	2024-02-14
2023-09-30	$2,729,393	210,115	+8.9%	Shares	Other	2023-11-01
2023-06-30	$2,455,527	192,893	—	Shares	Other	2023-07-27
No filing history on record for this holder in this stock.